US deal for Surgical Innovations
The agreement, effective from February 1, provides an opportunity for the Leeds firm, through Surgical Innovations US, its American distributor, to get access to the purchasing organisation's 2,200 member hospitals.
Surgical Innovations wants to increase the market for its Resposable laparoscopic instrumentation portfolio, Logi Range, an ergonomic system which combines re-usable handles with disposable scissor blades and graspers. It gives surgeons high quality, cost effective instruments for performing laparoscopic surgery.
Advertisement
Hide AdAdvertisement
Hide AdGraham Bowland, managing director of Surgical Innovations, said: "This agreement with one of the US's leading GPOs strengthens SI's strategy of developing the LogiRange brand through our collaboration with SI USA.
"The 2,200 member hospitals represent a considerable proportion of all US hospitals, therefore the agreement provides us with significant access to the US laparoscopic instrumentation market, which is estimated to be worth $150 million per annum.
"We look forward to seeing substantial sales growth of the Logi Range as member hospitals are introduced to the brand."